Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.KCR, European Contract Research Organization (CRO), has purchased the whole portfolio of clinical projects from the Ukrainian CRO, AXIS Group.
Subscribe to our email newsletter
Terms of the transaction were not disclosed.
The deal is said to strengthen KCR’s presence in Ukraine, making the country an important location for the firm in the region of the Commonwealth of Independent States (CIS).
KCR president and CEO Mike Jagielski said: "KCR has a long and successful history of conducting clinical trials in Ukraine since we registered our subsidiary in the country in 2007.
"With the integration of 15 AXIS projects and almost the entire clinical operations team, we consider KCR as one of the key players in Ukraine in regards to trials execution."
KCR is well positioned to be a strategic CRO for pharma and biopharma companies, with its long term presence in the country, broad base of local contacts, a team of 40 experienced specialists, and an office located in the heart of Kyiv.
KCR’s offer includes a service, entitled "KCR Bridge Plus Program", specifically for companies willing to start their studies in Europe, including CEE and CIS regions, in an attempt to share its knowledge and experience of working in a broad European context.
With around 300 professionals operating across 19 countries in Europe as well as the US, KCR offer full service capabilities for Phase I-IV Clinical Development Projects across a wide range of therapeutic areas.
It also operates a Functional Service Provider (FSP) with strategic and tactical solutions in clinical operations, data management and expert sourcing.